Showing results (71-80 of 80) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 80 results.
Hemasphere|June 26, 2024
Metabolic blood profile and response to treatment with the pyruvate kinase activator mitapivat in patients with sickle cell diseaseMyrthe J van Dijk, Titine J J Ruiter, Sigrid van der Veen, et al.
Bone Marrow Transplantation|July 30, 2025
Outcomes following different upfront stem cell transplantation strategies for multiple myeloma: a statistical perspective on behalf of the Chronic Malignancies Working Party of the EBMTSimona Iacobelli, Stefan Schönland, Linda Koster, et al.
Blood|March 17, 2024
An international learning collaborative phase 2 trial for haploidentical bone marrow transplant in sickle cell diseaseAdetola A Kassim, Josu de la Fuente, Erfan Nur, et al.
Blood Advances|November 26, 2025
Humoral and cellular immune response after COVID-19 vaccination in patients with sickle cell disease on hydroxyureaSabine Haggenburg, Cilia R Pothast, Quincy Hofsink, et al.
Bone Marrow Transplantation|December 24, 2025
A European survey on allogeneic haematopoietic cell transplantation for myelofibrosis on behalf of the Chronic Malignancies Working Party of the EBMT: focus on 'real world' experience of JAK inhibitors, splenomegaly management and novel agents in the transplant algorithmAlexandros Rampotas, Jose Maria Aspa-Cilleruelo, Linda Koster, et al.
American Journal of Hematology|July 4, 2026
Undetectable Hydroxyurea Levels in the Majority of Sickle Cell Disease Patients, Especially in Young ChildrenSigrid van der Veen, Bart J Biemond, Marjon H Cnossen, et al.
The New England Journal of Medicine|January 5, 2022
Eltrombopag Added to Immunosuppression in Severe Aplastic AnemiaRégis Peffault de Latour, Austin Kulasekararaj, Simona Iacobelli, et al.
American Journal of Hematology|July 19, 2026
Eltrombopag Added to Standard Immunosuppressive Treatment as Front-Line Therapy for Severe Aplastic Anemia: Long-Term Outcomes of the Phase-3 Randomized Superiority EBMT-SAAWP RACE StudyAntonio M Risitano, Simona Iacobelli, Austin Kulasekararaj, et al.
Orphanet Journal of Rare Diseases|April 16, 2025
COVID- 19 in patients affected by red blood cell disorders, results from the European registry ERN-EuroBloodNetPablo Velasco Puyo, Soteroula Christou, Saveria Campisi, et al.
Blood Advances|February 24, 2026
Humoral and cellular immune response after COVID-19 vaccination in patients with sickle cell disease on hydroxyureaSabine Haggenburg, Cilia R Pothast, Quincy Hofsink, et al.
Pageof 8